MedTrace Logo

Web-Based and Tailored Asthma Management Intervention (Puff City) in Teens With Asthma Attending Urban Clinics

NCT01757002 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2017-08-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the Puff City web-based behavioral intervention of asthma management program in a clinical setting. This study also examines and evaluates the cost and efficiency of patient eligibility determination methods, patient recruitment, study monitoring (compliance with study regimen, participant retention and follow-up), and the collection of clinical endpoints.

Conditions

Interventions

BEHAVIORAL

Teens randomized to the experimental arm will receive 4 sessions plus a booster of web-based, tailored asthma management.

Web-based, computer-tailored asthma management intervention delivered in 4 sessions, plus a 6 month booster.

BEHAVIORAL

Teens in the control group will receive generic, web-based asthma education.

Web-based, generic asthma management intervention delivered in 4 sessions.

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • Augusta University

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Mei Lu, PhD · Henry Ford Health System

  • Christine Joseph, PhD · Henry Ford Health System

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-05-31
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01757002 on ClinicalTrials.gov